Depreciation of Vaxart, Inc. from 30 Jun 2011 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
Vaxart, Inc. quarterly and annual Depreciation in USD history and change rate from 30 Jun 2011 to 30 Sep 2025.
  • Vaxart, Inc. Depreciation for the quarter ending 30 Sep 2025 was $900,000, a 10% decline year-over-year.
  • Vaxart, Inc. Depreciation for the twelve months ending 30 Sep 2025 was $3,600,000, a 5.3% decline year-over-year.
  • Vaxart, Inc. annual Depreciation for 2024 was $3,700,000, a 2.6% decline from 2023.
  • Vaxart, Inc. annual Depreciation for 2023 was $3,800,000, a 90% increase from 2022.
  • Vaxart, Inc. annual Depreciation for 2022 was $2,000,000, a 173% increase from 2021.
Source SEC data
View on sec.gov
Depreciation, Trailing 12 Months (USD)
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Change (%)
Depreciation, Annual (USD)
Depreciation, YoY Annual Change (%)

Vaxart, Inc. Quarterly Depreciation (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $3,600,000 $900,000 -$100,000 -10% 01 Jul 2025 30 Sep 2025 10-Q 13 Nov 2025 2025 Q3
Q2 2025 $3,700,000 $900,000 $0 0% 01 Apr 2025 30 Jun 2025 10-Q 13 Aug 2025 2025 Q2
Q1 2025 $3,700,000 $900,000 $0 0% 01 Jan 2025 31 Mar 2025 10-Q 13 May 2025 2025 Q1
Q4 2024 $3,700,000 $900,000 -$100,000 -10% 01 Oct 2024 31 Dec 2024 10-K 20 Mar 2025 2024 FY
Q3 2024 $3,800,000 $1,000,000 $0 0% 01 Jul 2024 30 Sep 2024 10-Q 13 Nov 2025 2025 Q3
Q2 2024 $3,800,000 $900,000 $0 0% 01 Apr 2024 30 Jun 2024 10-Q 13 Aug 2025 2025 Q2
Q1 2024 $3,800,000 $900,000 $0 0% 01 Jan 2024 31 Mar 2024 10-Q 13 May 2025 2025 Q1
Q4 2023 $3,800,000 $1,000,000 +$317,000 +46% 01 Oct 2023 31 Dec 2023 10-K 20 Mar 2025 2024 FY
Q3 2023 $3,483,000 $1,000,000 +$500,000 +100% 01 Jul 2023 30 Sep 2023 10-Q 13 Nov 2024 2024 Q3
Q2 2023 $2,983,000 $900,000 +$453,000 +101% 01 Apr 2023 30 Jun 2023 10-Q 08 Aug 2024 2024 Q2
Q1 2023 $2,530,000 $900,000 +$530,000 +143% 01 Jan 2023 31 Mar 2023 10-Q 13 May 2024 2024 Q1
Q4 2022 $2,000,000 $683,000 +$357,000 +110% 01 Oct 2022 31 Dec 2022 10-K 14 Mar 2024 2023 FY
Q3 2022 $1,643,000 $500,000 +$289,000 +137% 01 Jul 2022 30 Sep 2022 10-Q 02 Nov 2023 2023 Q3
Q2 2022 $1,354,000 $447,000 +$327,000 +272% 01 Apr 2022 30 Jun 2022 10-Q 03 Aug 2023 2023 Q2
Q1 2022 $1,027,000 $370,000 +$295,000 +393% 01 Jan 2022 31 Mar 2022 10-Q 09 May 2022 2022 Q1
Q4 2021 $732,000 $326,000 +$290,000 +806% 01 Oct 2021 31 Dec 2021 10-K 15 Mar 2023 2022 FY
Q3 2021 $442,000 $211,000 +$177,000 +521% 01 Jul 2021 30 Sep 2021 10-Q 09 Nov 2022 2022 Q3
Q2 2021 $265,000 $120,000 +$95,000 +380% 01 Apr 2021 30 Jun 2021 10-Q 08 Aug 2022 2022 Q2
Q1 2021 $170,000 $75,000 +$56,000 +295% 01 Jan 2021 31 Mar 2021 10-Q 09 May 2022 2022 Q1
Q4 2020 $114,000 $36,000 -$82,000 -69% 01 Oct 2020 31 Dec 2020 10-K 24 Feb 2022 2021 FY
Q3 2020 $196,000 $34,000 -$97,000 -74% 01 Jul 2020 30 Sep 2020 10-Q 04 Nov 2021 2021 Q3
Q2 2020 $293,000 $25,000 -$100,000 -80% 01 Apr 2020 30 Jun 2020 10-Q 05 Aug 2021 2021 Q2
Q1 2020 $393,000 $19,000 -$111,000 -85% 01 Jan 2020 31 Mar 2020 10-Q 06 May 2021 2021 Q1
Q4 2019 $504,000 $118,000 -$9,000 -7.1% 01 Oct 2019 31 Dec 2019 10-K 24 Feb 2022 2021 FY
Q3 2019 $513,000 $131,000 +$1,000 +0.77% 01 Jul 2019 30 Sep 2019 10-Q 12 Nov 2020 2020 Q3
Q2 2019 $512,000 $125,000 +$4,000 +3.3% 01 Apr 2019 30 Jun 2019 10-Q 06 Aug 2020 2020 Q2
Q1 2019 $508,000 $130,000 +$32,000 +33% 01 Jan 2019 31 Mar 2019 10-Q 12 May 2020 2020 Q1
Q4 2018 $476,000 $127,000 +$43,000 +51% 01 Oct 2018 31 Dec 2018 10-K 25 Feb 2021 2020 FY
Q3 2018 $433,000 $130,000 +$39,000 +43% 01 Jul 2018 30 Sep 2018 10-Q 12 Nov 2019 2019 Q3
Q2 2018 $394,000 $121,000 +$16,000 +15% 01 Apr 2018 30 Jun 2018 10-Q 08 Aug 2019 2019 Q2
Q1 2018 $378,000 $98,000 +$2,000 +2.1% 01 Jan 2018 31 Mar 2018 10-Q 09 May 2019 2019 Q1
Q4 2017 $376,000 $84,000 01 Oct 2017 31 Dec 2017 10-K 06 Feb 2019 2018 FY
Q3 2017 $91,000 01 Jul 2017 30 Sep 2017 10-Q 13 Nov 2018 2018 Q3
Q2 2017 $105,000 01 Apr 2017 30 Jun 2017 10-Q 10 Aug 2018 2018 Q2
Q1 2017 $96,000 01 Jan 2017 31 Mar 2017 10-Q 15 May 2018 2018 Q1

Vaxart, Inc. Annual Depreciation (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 $3,700,000 -$100,000 -2.6% 01 Jan 2024 31 Dec 2024 10-K 20 Mar 2025 2024 FY
2023 $3,800,000 +$1,800,000 +90% 01 Jan 2023 31 Dec 2023 10-K 20 Mar 2025 2024 FY
2022 $2,000,000 +$1,268,000 +173% 01 Jan 2022 31 Dec 2022 10-K 14 Mar 2024 2023 FY
2021 $732,000 +$618,000 +542% 01 Jan 2021 31 Dec 2021 10-K 15 Mar 2023 2022 FY
2020 $114,000 -$390,000 -77% 01 Jan 2020 31 Dec 2020 10-K 24 Feb 2022 2021 FY
2019 $504,000 +$28,000 +5.9% 01 Jan 2019 31 Dec 2019 10-K 24 Feb 2022 2021 FY
2018 $476,000 +$100,000 +27% 01 Jan 2018 31 Dec 2018 10-K 25 Feb 2021 2020 FY
2017 $376,000 01 Jan 2017 31 Dec 2017 10-K 06 Feb 2019 2018 FY
2013 $1,800,000 $0 0% 01 Jul 2012 30 Jun 2013 10-K 27 Sep 2013 2013 FY
2012 $1,800,000 +$100,000 +5.9% 01 Jul 2011 30 Jun 2012 10-K 27 Sep 2013 2013 FY
2011 $1,700,000 01 Jul 2010 30 Jun 2011 10-K 27 Sep 2013 2013 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.